분자유전학실험실 (단국대학교 분자생물학과)



 이성욱 ( 2013-02-16 03:34:24 , Hit : 2287
 Newly Identified Natural Protein Blocks HIV, Other Viruses

Science News


Feb. 11, 2013 — A team of UCLA-led researchers has identified a protein with broad virus-fighting properties that potentially could be used as a weapon against deadly human pathogenic viruses such as HIV, Ebola, Rift Valley Fever, Nipah and others designated "priority pathogens" for national biosecurity purposes by the National Institute of Allergy and Infectious Disease.


In a study published in the January issue of the journal Immunity, the researchers describe the novel antiviral property of the protein, cholesterol-25-hydroxylase (CH25H), an enzyme that converts cholesterol to an oxysterol called 25-hydroxycholesterol (25HC), which can permeate a cell's wall and block a virus from getting in.

Interestingly, the CH25H enzyme is activated by interferon, an essential antiviral cell-signaling protein produced in the body, said lead author Su-Yang Liu, a student in the department of microbiology, immunology and molecular genetics at the David Geffen School of Medicine at UCLA.

"Antiviral genes have been hard to apply for therapeutic purposes because it is difficult to express genes in cells," said Liu, who performed the study with principal investigator Genhong Cheng, a professor of microbiology, immunology and molecular genetics. "CH25H, however, produces a natural, soluble oxysterol that can be synthesized and administered.

"Also, our initial studies showing that 25HC can inhibit HIV growth in vivo should prompt further study into membrane-modifying cholesterols that inhibit viruses," he added.

The discovery is particularly relevant to efforts to develop broad-spectrum antivirals against an increasing number of emerging viral pathogens, Liu said.

Working with Jerome Zack, a professor of microbiology, immunology and molecular genetics and an associate director of the UCLA AIDS Institute, the researchers initially found that 25HC dramatically inhibited HIV in cell cultures. Next, they administered 25HC in mice implanted with human tissues and found that it significantly reduced their HIV load within seven days. The 25HC also reversed the T-cell depletion caused by HIV.

By contrast, mice that had the CH25H gene knocked out were more susceptible to a mouse gammaherpes virus, the researchers found.

In collaboration with Dr. Benhur Lee, a professor of pathology and laboratory medicine and a member of the UCLA AIDS Institute, they discovered that 25HC inhibited HIV entry into the cell. Furthermore, in cell cultures, it was found to inhibit the growth of other deadly viruses, such as Ebola, Nipah and the Rift Valley Fever virus.

Intriguingly, CH25H expression in cells requires interferon. While interferon has been known for more than 60 years to be a critical part of the body's natural defense mechanism against viruses, the protein itself does not have any antiviral properties. Rather, it triggers the expression of many antiviral genes. While other studies have identified some antiviral genes that are activated by interferon, this research gives the first description of an interferon-induced antiviral oxysterol through the activation of the enzyme CH25H. It provides a link to how interferon can cause inhibition of viral membrane fusion, Liu said.

He noted some weaknesses in the research. For instance, 25HC is difficult to deliver in large doses, and its antiviral effect against Ebola, Nipah and other highly pathogenic viruses have yet to be tested in vivo. Also, the researchers still need to compare 25HC's antiviral effect against other HIV antivirals.

Additional study co-authors were Roghiyh Aliyari, Kelechi Chikere, Matthew D. Marsden and Olivier Pernet, of UCLA; Jennifer K. Smith, Rebecca Nusbaum and Alexander N. Frieberg, of the University of Texas-Galveston; and Guangming Li, Haitao Guo and Lishan Su, of the University of North Carolina-Chapel Hill.

The National Institutes of Health (grants R01 AI078389, AI069120, AI080432, AI095097, AI077454, AI070010 and AI028697), the Warsaw Fellowship, the UCLA Center for AIDS Research (CFAR), the UCLA AIDS Institute, the UCLA Clinical and Translational Science Institute (CTSI), and the Pacific Southwest Regional Center of Excellence (PSWRCE) for Biodefense and Emerging Infectious Diseases funded this study.



--------------------------------------------------------------------------------

Story Source:


The above story is reprinted from materials provided by University of California, Los Angeles (UCLA), Health Sciences.

Note: Materials may be edited for content and length. For further information, please contact the source cited above.


--------------------------------------------------------------------------------

Journal Reference:
1.Su-Yang Liu, Roghiyh Aliyari, Kelechi Chikere, Guangming Li, Matthew D. Marsden, Jennifer K. Smith, Olivier Pernet, Haitao Guo, Rebecca Nusbaum, Jerome A. Zack, Alexander N. Freiberg, Lishan Su, Benhur Lee, Genhong Cheng. Interferon-Inducible Cholesterol-25-Hydroxylase Broadly Inhibits Viral Entry by Production of 25-Hydroxycholesterol. Immunity, 2013; 38 (1): 92 DOI: 10.1016/j.immuni.2012.11.005







767   인간 게놈 백과사전 완성: 게놈은 유전자의 단순한 집합체가 아니다  이성욱 2012/09/10 2792
766   유전자 요법의 후각기능 회복  이성욱 2012/09/12 3160
765   “몸매는 날씬해야” 강박관념도 유전자 탓  이성욱 2012/10/04 2678
764   日 교토대, 쥐 유도만능줄기세포로 난자 만들어  이성욱 2012/10/06 3207
763   The Nobel Prize in Physiology or Medicine 2012  이성욱 2012/10/09 2577
762   Smallest and fastest-known RNA switches provide new drug targets  이성욱 2012/10/11 2492
761   Early-Earth cells modeled to show how first life forms might have packaged RNA  이성욱 2012/10/16 2587
760   유도만능줄기세포, 진짜 만능일까?  이성욱 2012/10/17 2722
759   Nobel work boosts drug development  이성욱 2012/10/23 2571
758   Whitehead scientists identify major flaw in standard approach to global gene expression analysis  이성욱 2012/10/29 2252
757   유럽 첫 유전자 치료제 승인 지단백 리파제 결핍약 '글리베라' 허가  이성욱 2012/11/06 3980
756   CU-Boulder researchers uncover new target for cancer research  이성욱 2012/11/06 2758
755   Genomics: The single life  이성욱 2012/11/06 2134
754   Glybera Gains Official EMA Nod as First Gene Therapy  이성욱 2012/11/06 2684
753   술 퍼먹게 하는 유전자 있다  이성욱 2012/12/07 2889
752   Biopharma startup raises $51M for therapeutic to treat bleeding complications from angioplasty  이성욱 2012/12/22 2546
751   뇌의 신비 밝혀줄 지도가 만들어진다 - 올해는 휴먼 커넥톰 프로젝트가 완료되는 해  이성욱 2013/02/05 3534
  Newly Identified Natural Protein Blocks HIV, Other Viruses  이성욱 2013/02/16 2287
749   'Activating' RNA takes DNA on a loop through time and space  이성욱 2013/02/19 2159
748   Electronics Giant Samsung Makes First Big Biotech Play  이성욱 2013/02/22 3205

[이전 10개] [1]..[21][22][23][24][25] 26 [27][28][29][30]..[64] [다음 10개]
 

Copyright 1999-2024 Zeroboard / skin by ROBIN